Page last updated: 2024-10-26

famotidine and Esophageal Varices

famotidine has been researched along with Esophageal Varices in 2 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahoshi, T1
Kawanaka, H1
Tomikawa, M1
Saeki, H1
Uchiyama, H1
Ikeda, T1
Shirabe, K1
Hashizume, M1
Maehara, Y1
Tanaka, J1
Fujimoto, K1
Iwakiri, R1
Koyama, T1
Sakata, H1
Ohyama, T1
Mizuguchi, M1
Tokunaga, O1

Trials

1 trial available for famotidine and Esophageal Varices

ArticleYear
Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:12

    Topics: Aged; Esophageal and Gastric Varices; Esophageal pH Monitoring; Esophagitis, Peptic; Famotidine; Fem

2013

Other Studies

1 other study available for famotidine and Esophageal Varices

ArticleYear
Hyperplastic polyps following treatment of acute gastric ulcers.
    Internal medicine (Tokyo, Japan), 1994, Volume: 33, Issue:6

    Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Po

1994